Stocks and Investing Stocks and Investing
Wed, March 10, 2021
Tue, March 9, 2021
Mon, March 8, 2021
Fri, March 5, 2021
Thu, March 4, 2021

Thomas Smith Maintained (ACRS) at Buy with Increased Target to $26 on, Mar 4th, 2021


Published on 2024-10-27 15:51:09 - WOPRAI, Thomas Smith
  Print publication without navigation


Thomas Smith of SVB Leerink, Maintained "Aclaris Therapeutics, Inc." (ACRS) at Buy with Increased Target from $21 to $26 on, Mar 4th, 2021.

Thomas, nor any peers, have made any analyst calls on ACRS in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30